Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20143360 | 1.00 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL13070334 | 1.00 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL19277005 | 1.00 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL20880901 | 0.85 | TDP1 (0.31) | TDP1 | |
| SCHEMBL19308712 | 0.83 | TDP1 (0.36) | TDP1TSHR | |
| SCHEMBL24316732 | 0.82 | TDP1 (0.40) | TDP1TSHR | |
| SCHEMBL2305046 | 0.82 | TDP1 (0.44) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL15966302 | 0.81 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL16729464 | 0.81 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR | |
| SCHEMBL19592300 | 0.81 | TDP1 (0.35) | TDP1LMNAL3MBTL1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9802996-B2 | Glycosylated polypeptide and drug composition containing said polypeptide | GLYTECH, INC. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-20170157260-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GLYTECH, INC. (JP) | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170157260-A1 | Glycosylated Polypeptide and Drug Composition Containing said Polypeptide | GIPR, SSTR4, SSTR3 | TDP1 2969/4885LMNA 2286/4885L3MBTL1 3716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.